Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts
- PMID: 9459146
- PMCID: PMC2151270
- DOI: 10.1038/bjc.1998.9
Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts
Abstract
A method is presented in this report for concurrent analysis of vascular architecture, blood perfusion and proliferation characteristics in whole-tumour cross-sections of human larynx carcinoma and glioblastoma xenografts. Tumours were implanted subcutaneously in nude mice. After i.v. injection with Hoechst 33342 and bromodeoxyuridine (BrdUrd) as perfusion and proliferation markers, animals were killed. An antiendothelial antibody (9F1) was used to delineate vascular structures. Cross-sections were analysed by a multistep immune staining and a computer-controlled microscope scanning method. Each tumour section was stained and scanned four times (Hoechst, 9F1, BrdUrd and Fast Blue for all nuclei). When these images were combined, vasculature, perfusion and proliferation parameters were analysed. The labelling index (LI) was defined as the ratio of the BrdUrd-labelled area to the total nuclear area. The LI based on manual counting and the LI calculated by flow cytometry (FCM) were in good agreement with the LI based on surface analysis. LI decreased at increasing distance from its nearest vessel. In the vicinity of perfused vessels, the LI was 30-70% higher than near non-perfused vessels. This method shows that both vasculature/perfusion and proliferation characteristics can be measured in the same whole-tumour section in a semiautomatic way. This could be applied in clinical practice to identify combined human tumour characteristics that predict for a favourable response to treatment modifications.
Similar articles
-
Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1.Anticancer Res. 2005 Mar-Apr;25(2A):1015-21. Anticancer Res. 2005. PMID: 15868941
-
Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide.Radiother Oncol. 1999 Feb;50(2):173-84. doi: 10.1016/s0167-8140(99)00010-9. Radiother Oncol. 1999. PMID: 10368041
-
Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas.Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):215-28. doi: 10.1016/s0360-3016(02)02938-3. Int J Radiat Oncol Biol Phys. 2002. PMID: 12182995
-
Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.Cell Prolif. 1996 Mar;29(3):141-52. Cell Prolif. 1996. PMID: 8652743
-
Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.Cytometry. 1992;13(8):872-9. doi: 10.1002/cyto.990130810. Cytometry. 1992. PMID: 1459003
Cited by
-
Assessment of Blood Hemodynamics by USPIO-Induced R(1) Changes in MRI of Murine Colon Carcinoma.Appl Magn Reson. 2010 Jun;38(3):349-360. doi: 10.1007/s00723-010-0124-1. Epub 2010 Mar 28. Appl Magn Reson. 2010. PMID: 20502507 Free PMC article.
-
Dasatinib Inhibits DNA Repair after Radiotherapy Specifically in pSFK-Expressing Tumor Areas in Head and Neck Xenograft Tumors.Transl Oncol. 2013 Aug 1;6(4):413-9. doi: 10.1593/tlo.13259. Print 2013 Aug. Transl Oncol. 2013. PMID: 23908684 Free PMC article.
-
Endocytotic uptake of HPMA-based polymers by different cancer cells: impact of extracellular acidosis and hypoxia.Int J Nanomedicine. 2017 Aug 3;12:5571-5584. doi: 10.2147/IJN.S136952. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28831253 Free PMC article.
-
Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma.Int J Clin Exp Pathol. 2013 Nov 15;6(12):2651-67. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24294352 Free PMC article.
-
Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.Neoplasia. 2015 Feb;17(2):215-24. doi: 10.1016/j.neo.2014.12.011. Neoplasia. 2015. PMID: 25748241 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical